Cassra B. Clark
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cassra B. Clark has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Costas D Lallas
Department of Urology Sidney Kimmel Medical College Thomas Jefferson University, Philadelphia, PA, USA
1 shared publication- Edouard John Trabulsi
Jefferson Einstein Medical Center, Philadelphia, Pennsylvania
1 shared publication Erik B. Lehman
1 shared publicationHimi Begum
1 shared publication- James Ryan Mark
Thomas Jefferson University Hospital, Philadelphia, PA
1 shared publication - Jay Dilip Raman
Penn State Health Milton S. Hershey Medical Center
1 shared publication
Latest Publications
- Open Access
- 1 April 2026
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 15 (4) , 109
Transforming postoperative follow-up: telemedicine trends in radical prostatectomy patients
The coronavirus disease 2019 (COVID-19) pandemic ushered in the widespread adoption of telemedicine in the healthcare landscape. Telemedicine utilization has persisted beyond the pandemic and is considered an acceptable method of surveilling cancer patients. Oncologic surveillance following radical prostatectomy (RP) involves checking serum prostate specific antigen (PSA) and theoretically is well suited for telemedicine. We compare demographic data and clinical traits of patients undergoing in-person vs. telemedicine surveillance after prostatectomy. A retrospective cohort study of RP patients for a single surgeon with clinic visits occurring between January 2021–April 2024 was performed. For data entry and analysis, the most recent visit for each unique patient was used even if multiple visits occurred during the study. Patient distance from hospital was calculated using CDXGeoData API software and representative map produced on Google Maps. For bivariate statistical analysis, Wilcoxon Rank Sum test was used for continuous variables and Chi-squared and two sampled t-test were used for categorical variables. For multivariate statistical analysis, logistic regression was used. Four hundred and ninety-one patients were included of which 283 (58%) visits were in-person and 208 (42%) were telemedicine. On bivariate analysis, compared to in-person visits, patients utilizing telemedicine lived a greater distance from the hospital (P<0.001). Race was significantly associated with visit modality (P=0.046), with White patients demonstrating higher utilization of telemedicine. In contrast, cancer recurrence (P=0.04) and active androgen deprivation therapy (ADT) use (P=0.01) were significantly associated with in-person encounters. Erectile dysfunction (ED), stress urinary incontinence (SUI), marital status, pathologic stage, and PSA nadir were not significantly associated with visit type. On multivariate analysis, only younger age [odds ratio (OR) 0.846, 95% confidence interval (CI): 0.742–0.964] and White race (OR 0.406, 95% CI: 0.182–0.907) were independently associated with telemedicine use. Telemedicine offers an effective and patient centric method of surveillance after RP. Targeted efforts are needed to address sociodemographic factors that influence its utilization.
- 1 April 2026
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 15 (4) , 109
Open AccessTransforming postoperative follow-up: telemedicine trends in radical prostatectomy patients
The coronavirus disease 2019 (COVID-19) pandemic ushered in the widespread adoption of telemedicine in the healthcare landscape. Telemedicine utilization has persisted beyond the pandemic and is considered an acceptable method of surveilling cancer patients. Oncologic surveillance following radical prostatectomy (RP) involves checking serum prostate specific antigen (PSA) and theoretically is well suited for telemedicine. We compare demographic data and clinical traits of patients undergoing in-person vs. telemedicine surveillance after prostatectomy. A retrospective cohort study of RP patients for a single surgeon with clinic visits occurring between January 2021–April 2024 was performed. For data entry and analysis, the most recent visit for each unique patient was used even if multiple visits occurred during the study. Patient distance from hospital was calculated using CDXGeoData API software and representative map produced on Google Maps. For bivariate statistical analysis, Wilcoxon Rank Sum test was used for continuous variables and Chi-squared and two sampled t-test were used for categorical variables. For multivariate statistical analysis, logistic regression was used. Four hundred and ninety-one patients were included of which 283 (58%) visits were in-person and 208 (42%) were telemedicine. On bivariate analysis, compared to in-person visits, patients utilizing telemedicine lived a greater distance from the hospital (P<0.001). Race was significantly associated with visit modality (P=0.046), with White patients demonstrating higher utilization of telemedicine. In contrast, cancer recurrence (P=0.04) and active androgen deprivation therapy (ADT) use (P=0.01) were significantly associated with in-person encounters. Erectile dysfunction (ED), stress urinary incontinence (SUI), marital status, pathologic stage, and PSA nadir were not significantly associated with visit type. On multivariate analysis, only younger age [odds ratio (OR) 0.846, 95% confidence interval (CI): 0.742–0.964] and White race (OR 0.406, 95% CI: 0.182–0.907) were independently associated with telemedicine use. Telemedicine offers an effective and patient centric method of surveillance after RP. Targeted efforts are needed to address sociodemographic factors that influence its utilization.
- Open Access
- 1 January 2024
- Published by Wiley in Advances in Urology
- Vol. 2024 (1) , 3439727
Complications and Influential Perioperative Factors Associated with SpaceOAR Hydrogel Placement
Objective. To examine one academic institution’s experiences with SpaceOAR placement, its associated complications, and periprocedural characteristics that affect outcomes for the purpose of quality improvement. Materials and Methods. We conducted a retrospective review of 233 patients who received SpaceOAR from four surgeons and one radiation oncologist between 2018 and 2021. Variables such as demographics, oncologic parameters, radiation plan, and radiographic assessment of hydrogel placement were recorded. The Charlson Comorbidity Index (CCI) was used to assess comorbidity risk. Mann–Whitney and Fisher’s exact tests were performed to compare patients with and without complications. Results. Of the 233 patients who received SpaceOAR, 24 (10.3%) experienced toxicity. All complications were Clavien I or II, such as pelvic pain postplacement, pelvic fullness, bleeding, and lower urinary tract symptoms. 16 patients (6.9%) had some portion of the hydrogel injected into the rectal wall, but it was never clinically significant. The average CCI was 3.2 ± 0.95 for patients who experienced complications; the average CCI was 3.6 ± 1.6 (p = 0.48) in the group without complications. Of the physicians with higher procedure volumes, Physician #1 had the highest rate of patient‐reported complications at 11 out of 68 (16.2%) and Physician #2 had the lowest rate of complications at 4 out of 96 placements (4.2%). Multivariate analysis found that patients who had received hormone therapy previously had less odds of reporting complications after SpaceOAR placement. Conclusions. The listed attending on the procedure had a significant correlation to complications with SpaceOAR placement on univariate analysis, and hormone therapy had some benefits to the tolerance for the procedure on multivariate analysis. Overall, the hydrogel placement was well tolerated with low incidence of mild and transient procedure‐related toxicity.
- 1 January 2024
- Published by Wiley in Advances in Urology
- Vol. 2024 (1) , 3439727
Open AccessComplications and Influential Perioperative Factors Associated with SpaceOAR Hydrogel Placement
Objective. To examine one academic institution’s experiences with SpaceOAR placement, its associated complications, and periprocedural characteristics that affect outcomes for the purpose of quality improvement. Materials and Methods. We conducted a retrospective review of 233 patients who received SpaceOAR from four surgeons and one radiation oncologist between 2018 and 2021. Variables such as demographics, oncologic parameters, radiation plan, and radiographic assessment of hydrogel placement were recorded. The Charlson Comorbidity Index (CCI) was used to assess comorbidity risk. Mann–Whitney and Fisher’s exact tests were performed to compare patients with and without complications. Results. Of the 233 patients who received SpaceOAR, 24 (10.3%) experienced toxicity. All complications were Clavien I or II, such as pelvic pain postplacement, pelvic fullness, bleeding, and lower urinary tract symptoms. 16 patients (6.9%) had some portion of the hydrogel injected into the rectal wall, but it was never clinically significant. The average CCI was 3.2 ± 0.95 for patients who experienced complications; the average CCI was 3.6 ± 1.6 (p = 0.48) in the group without complications. Of the physicians with higher procedure volumes, Physician #1 had the highest rate of patient‐reported complications at 11 out of 68 (16.2%) and Physician #2 had the lowest rate of complications at 4 out of 96 placements (4.2%). Multivariate analysis found that patients who had received hormone therapy previously had less odds of reporting complications after SpaceOAR placement. Conclusions. The listed attending on the procedure had a significant correlation to complications with SpaceOAR placement on univariate analysis, and hormone therapy had some benefits to the tolerance for the procedure on multivariate analysis. Overall, the hydrogel placement was well tolerated with low incidence of mild and transient procedure‐related toxicity.